Luporini 1979.
| Study characteristics | |||
| Patient sampling |
Country Italy Study design retrospective Setting Hospital Dates of data collection 1974 ‐ 1976 Population (n) 204 Inclusion criteria Large bowel malignancies, radical resection Exclusion criteria N/R Participants Included (n) 198 |
||
| Patient characteristics and setting |
Age range N/R Smoking status N/R Site of primary tumour Large intestine Stage of primary tumour Dukes A ‐ B 11, C1 39, C2 30, CH (liver involvement) 32 Perioperative investigations done to ensure no residual disease N/R Chemotherapy/radiotherapy? Yes Recurrences (n) 62 Site of recurrences N/R |
||
| Index tests |
CEA timing N/R CEA technique N/R CEA threshold 5 µg/L Definition of positive N/R Which CEA value (s) used? N/R More data available? N/R |
||
| Target condition and reference standard(s) |
Follow‐up schedule N/R |
||
| Flow and timing |
Timing of CEA vs reference standard (days) Unclear |
||
| Comparative | |||
| Notes | |||
| Methodological quality | |||
| Item | Authors' judgement | Risk of bias | Applicability concerns |
| DOMAIN 1: Patient Selection | |||
| Was a consecutive or random sample of patients enrolled? | Unclear | ||
| Did the study avoid inappropriate exclusions? | Unclear | ||
| Unclear | Low | ||
| DOMAIN 2: Index Test All CEA thresholds | |||
| If a threshold was used, was it pre‐specified? | Yes | ||
| Is the same method and instrument used for all CEA measurements? | Unclear | ||
| Is there an estimation of reproducibility of the method, for example the % coefficient of variation at specific concentrations? | No | ||
| Is there an indication of method accuracy, for example, is there evidence of participation in an external quality assessment and proficiency testing scheme? | No | ||
| Unclear | Low | ||
| DOMAIN 3: Reference Standard | |||
| Is the reference standards likely to correctly classify the target condition? | Unclear | ||
| Were the reference standard results interpreted without knowledge of the results of the index tests? | No | ||
| Unclear | Low | ||
| DOMAIN 4: Flow and Timing | |||
| Did all patients receive the same reference standard? | Unclear | ||
| Were all patients included in the analysis? | Unclear | ||
| Was the index test repeated prior to the reference standard? | Unclear | ||
| Was the the timing between index test(s) and reference standard ascertainable? | Unclear | ||
| Did all patients receive a reference standard? | Unclear | ||
| Unclear | |||